We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Owlstone Medical Raises $15 million USD to Drive Commercialization of its Breath Biopsy Platform

News   Mar 05, 2018 | Original story from Owstone Medical

 
Owlstone Medical Raises $15 million USD to Drive Commercialization of its Breath Biopsy Platform

Billy Boyle, CEO, Owlstone Medical

 
 
 

RELATED ARTICLES

Stem Cells Regulate Their Fate by Altering Their Stiffness

News

Reducing the number of cells participating in condensation — the clustering of stem cells prior to differentiation — leads to the activation of an intrinsic differentiation program. These findings open new avenues for stem cell therapies.

READ MORE

Blood-brain Barrier Breakdown Early Marker of Human Cognitive Dysfunction

News

Individuals with early cognitive function develop brain capillary damage and blood-brain barrier breakdown in the hippocampus, regardless of amyloid beta/tau biomarker changes.

READ MORE

Researchers Pioneer Machine Learning to Speed Chemical Discoveries, Reduce Waste

News

Researchers are tapping a new set of capabilities in this field of artificial intelligence, combining artificial neural networks with infrared thermal imaging to control and interpret chemical reactions with precision and speed that far outpace conventional methods.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE